# Advisor Review - Gemini-3-Flash

**Role:** Academic advisor checking for fatal errors
**Model:** gemini-3-flash-preview (ai_studio)
**Paper:** paper.pdf
**Timestamp:** 2026-02-17T14:23:21.889202
**Route:** Direct Google API + PDF
**Tokens:** 18838 in / 639 out
**Response SHA256:** 5193975b0abb4868

---

I have reviewed the draft paper "State Minimum Wage Increases and the HCBS Provider Supply Crisis." My evaluation for fatal errors follows:

### 1. DATA-DESIGN ALIGNMENT
*   **Treatment timing vs. data coverage:** The paper uses T-MSIS data covering January 2018 through December 2023 (Section 3.1). Treatment cohorts are defined for 2019, 2020, 2021, 2022, and 2023 (Table 6).
*   **Post-treatment observations:** As noted in Table 6, the 2023 cohort contributes at least one post-treatment observation ($t=g=2023$). The RDD/DiD requirements are satisfied.

### 2. REGRESSION SANITY
*   **Standard Errors:** Across Tables 2, 3, and 5, standard errors are of reasonable magnitudes relative to the coefficients and outcomes (log points and small rates). No values exceed the fatal thresholds (e.g., Table 2 log_mw SE is 0.2583).
*   **Coefficients:** All coefficients for log outcomes (log_mw) are between -1 and 1, which is plausible for elasticities.
*   **Impossible Values:** $R^2$ values are between 0 and 1 (ranging from 0.509 to 0.985). No negative SEs or "NaN" values were found in the regression tables.

### 3. COMPLETENESS
*   **Placeholder values:** No "TBD", "PLACEHOLDER", or "XXX" strings were found. Tables are populated with data.
*   **Missing required elements:** Regression tables (Tables 2, 3, and 5) include sample sizes (N) and standard errors in parentheses.
*   **Incomplete analyses:** The paper mentions a "Dose-Response" (C.2) and "Monthly Specification" (C.3) in the Appendix. While the full tables for these are not shown in the primary results section, the point estimates and SEs are cited in the text of the appendix, and the primary analysis is fully documented.

### 4. INTERNAL CONSISTENCY
*   **Numbers match:** The Abstract cites an ATT of -0.0480 for providers and -0.1234 for beneficiaries, which matches Table 4. The TWFE beneficiary elasticity cited in the Abstract (-0.6097, SE 0.2881) matches Table 3, Column 2.
*   **Timing consistency:** The treatment cohorts defined in Section 4.2.2 and Table 6 are consistent with the event studies shown in Figures 3, 4, and 5.
*   **Specification consistency:** Controls (like log population in Table 2 Col 4) are clearly defined and applied consistently where stated.

**ADVISOR VERDICT: PASS**